NCT04128722View on ClinicalTrials.gov

TOPical Sirolimus in linGUal Microcystic Lymphatic Malformation -TOPGUN

PHASE2RecruitingINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

February 14, 2020

Primary Completion Date

February 13, 2025

Study Completion Date

July 31, 2025

Conditions
Lingual Microcystic Lymphatic Malformations
Interventions
DRUG

Sirolimus Oral Liquid Product 1mg/mL

0.5 mL to 1 mL according to the size of the lesion, once daily, on lingual microcystic lymphatic malformation

Trial Locations (3)

37044

RECRUITING

Univsersity of TOURS _ Service de Dermatologie, Tours

45000

WITHDRAWN

REGIONAL Hospital of ORLEANS -Service de Dermatologie, Orléans

75015

ACTIVE_NOT_RECRUITING

Hospital NECKER -AP-HP - Dermatology, Paris

All Listed Sponsors
lead

University Hospital, Tours

OTHER